{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-269347","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.058569+00:00","generated_at":"2026-06-08T23:14:43.670386+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Inovio receives 180-day Nasdaq extension for minimum bid; stock transferred to Capital Market","bullets":["Extension to April 29, 2024 to achieve $1.00 closing bid for 10 consecutive days.","Common stock transferred from Nasdaq Global Market to Capital Market effective Nov 2, 2023.","Failure to comply by April 29 may lead to delisting; company may appeal the determination.","Company will consider reverse stock split among options to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-269347","json":"https://secwatch.observer/filing/0001193125-23-269347.json","markdown":"https://secwatch.observer/filing/0001193125-23-269347.md","text":"https://secwatch.observer/filing/0001193125-23-269347.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312523269347/0001193125-23-269347-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312523269347/d580286d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T23:14:43.670386+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}